Schirripa, M., Zhang, W., Yang, D., Cao, S., Okazaki, S., Loupakis, F., . . . Lenz, H. (2018). NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients. PLoS One.
Chicago Style CitationSchirripa, Marta, et al. "NOS2 Polymorphisms in Prediction of Benefit From First-line Chemotherapy in Metastatic Colorectal Cancer Patients." PLoS One 2018.
Cita MLASchirripa, Marta, et al. "NOS2 Polymorphisms in Prediction of Benefit From First-line Chemotherapy in Metastatic Colorectal Cancer Patients." PLoS One 2018.
Atenció: Aquestes cites poden no estar 100% correctes.